Recombinant Mouse RNGTT Protein Pre-coupled Magnetic Beads

• Cat.No.: RNGTT-7694M-B
• Product Overview: The Recombnant protein was conjugated to magnetic beads. This ready-to-use, pre-coupled magnetic beads are in uniform particle size and narrow size distribution with large surface area, which is conducive to convenient and fast capture target molecules with high specificity and achieve magnetic separation. This product can be equipped with automation equipment for high-throughput operations.

Specification

• Source: HEK293
• Species: Mouse
• Form: Solution
• Particle size: ~2 μm
• Beads Surface: Hydrophilic
• Capacity: > 200 pmol rabbit IgG/ mg beads
• Applications: Immunoassay, In vitro diagnostics, cell sorting, Immunoprecipitation/Co-precipitation, Protein/antibody separation and purification.
• Stability: Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions.
• Storage: 2-8℃. Do not to freeze thaw the Beads
• Concentration: 10mg beads/mL
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: Rngtt RNA guanylyltransferase and 5-phosphatase [ Mus musculus ]
• Official Symbol: RNGTT
• Gene ID: 24018
• mRNA Refseq: NM_011884.2
• Protein Refseq: NP_036014.1
• UniProt ID: O55236

Reviews

04/04/2023

Its exceptional characteristics, coupled with the manufacturer's commitment to customer satisfaction, ensure that I can pursue my scientific investigations with confidence and success.

07/09/2022

This level of support becomes invaluable, allowing researchers to focus on their scientific objectives while receiving expert guidance alongside.

08/07/2020

Its consistent performance and reproducibility have been praised by scientists who have employed it in their studies, with many reporting outstanding results and a high level of satisfaction.

Q&As

Can RNGTT protein-based therapies be used in personalized medicine?

There is potential for RNGTT protein-based therapies to be tailored to individual patients based on their specific disease characteristics.

How can RNGTT protein be targeted for clinical therapy?

Targeting RNGTT protein may offer potential therapeutic strategies for autoimmune diseases and cancer.

Can RNGTT protein be targeted for the treatment of neurodegenerative diseases?

There is emerging research exploring the potential of targeting RNGTT protein in the context of neurodegenerative diseases.

How does RNGTT protein relate to the development of autoimmune diseases?

Dysregulation of protein glycosylation mediated by RNGTT protein has been implicated in the pathogenesis of autoimmune diseases.

What are the potential clinical implications of RNGTT protein deficiency?

RNGTT protein deficiency can lead to a range of disorders, including immune system dysregulation and developmental defects.